(Q36375683)

English

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma (English)

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

0 references

1 reference

based on heuristic

inferred from title

Helmut Jonuleit

6

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

12

object named as

Steinman RM

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

author name string

Thurner B

1

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Haendle I

2

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Röder C

3

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Dieckmann D

4

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Keikavoussi P

5

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Bender A

7

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Maczek C

8

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Schreiner D

9

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

von den Driesch P

10

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Bröcker EB

11

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Enk A

13

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Kämpgen E

14

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Schuler G

15

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

language of work or name

0 references

publication date

1 December 1999

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Journal of Experimental Medicine

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

190

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

11

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

1669-1678

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2195739

30 September 2017

Systemic administration of interleukin 2 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2195739

30 September 2017

Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4(+) T lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2195739

30 September 2017

Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2195739

30 September 2017

Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2195739

30 September 2017

Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2195739

30 September 2017

Dendritic cells and the control of immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2195739

30 September 2017

TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2195739

30 September 2017

The use of computer-assisted video image analysis for the quantification of CD8+ T lymphocytes producing tumor necrosis factor alpha spots in response to peptide antigens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2195739

30 September 2017

Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2195739

30 September 2017

Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2195739

30 September 2017

Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2195739

30 September 2017

Activation of human dendritic cells through CD40 cross-linking.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2195739

30 September 2017

New opportunities for the development of cancer immunotherapies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2195739

28 June 2018

Dendritic cells as adjuvants for immune-mediated resistance to tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2195739

28 June 2018

T cell defined tumor antigens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2195739

28 June 2018

Estimation of the frequencies of anti-MAGE-3 cytolytic T-lymphocyte precursors in blood from individuals without cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2195739

21 September 2018

Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2195739

21 September 2018

Immunology. Licence to kill

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2195739

21 September 2018

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2195739

21 September 2018

Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2195739

5 December 2018

Elevated serum levels of interleukin-10 in patients with metastatic malignant melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/10587357

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability

1 reference

https://pubmed.ncbi.nlm.nih.gov/10587357

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/10587357

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/10587357

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions

1 reference

https://pubmed.ncbi.nlm.nih.gov/10587357

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/10587357

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer vaccines

1 reference

https://pubmed.ncbi.nlm.nih.gov/10587357

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel methods to monitor antigen-specific cytotoxic T-cell responses in cancer immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10587357

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin 10 production by human melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/10587357

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1

1 reference

https://pubmed.ncbi.nlm.nih.gov/10587357

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1084/JEM.190.11.1669

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36375683&oldid=1790225769"